Bank of New York Mellon Corp - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 78 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$13,535
-74.2%
102,691
+0.0%
0.00%
Q2 2023$52,363
-19.0%
102,6720.0%0.00%
Q1 2023$64,683
-2.9%
102,6720.0%0.00%
Q4 2022$66,644
-62.3%
102,6720.0%0.00%
Q3 2022$177,000
+36.2%
102,672
-1.9%
0.00%
Q2 2022$130,000
-71.0%
104,612
-84.8%
0.00%
Q1 2022$448,000
-40.2%
687,1840.0%0.00%
Q4 2021$749,000
-40.0%
687,184
+0.1%
0.00%
Q3 2021$1,249,000
-26.1%
686,480
+7.2%
0.00%
Q2 2021$1,691,000
-52.9%
640,438
-35.7%
0.00%
-100.0%
Q1 2021$3,588,000
+57.0%
996,634
+9.9%
0.00%
Q4 2020$2,286,000
-1.8%
906,914
-1.9%
0.00%
-100.0%
Q3 2020$2,328,000
-23.3%
924,108
-0.1%
0.00%0.0%
Q2 2020$3,034,000
+48.9%
924,927
+11.2%
0.00%0.0%
Q1 2020$2,037,000
-37.3%
831,436
+20.8%
0.00%0.0%
Q4 2019$3,248,000
+17.3%
687,998
+6.4%
0.00%0.0%
Q3 2019$2,768,000
-26.5%
646,697
+0.1%
0.00%0.0%
Q2 2019$3,765,000
+69.8%
645,883
+12.2%
0.00%0.0%
Q1 2019$2,217,000
+107.4%
575,639
+0.7%
0.00%
Q4 2018$1,069,000
-44.4%
571,804
-4.8%
0.00%
Q3 2018$1,923,000
+5.4%
600,741
-0.6%
0.00%
Q2 2018$1,825,000
-24.9%
604,293
-2.5%
0.00%
-100.0%
Q1 2018$2,430,000
-4.1%
619,831
+1.2%
0.00%0.0%
Q4 2017$2,535,000
-33.3%
612,335
-1.0%
0.00%0.0%
Q3 2017$3,798,000
-0.2%
618,508
+1.1%
0.00%0.0%
Q2 2017$3,804,000
+0.3%
611,533
+2.2%
0.00%0.0%
Q1 2017$3,794,000
+20.4%
598,406
+1.6%
0.00%0.0%
Q4 2016$3,150,000
-0.6%
588,754
+4.7%
0.00%0.0%
Q3 2016$3,168,000
-5.3%
562,587
-7.7%
0.00%0.0%
Q2 2016$3,347,000
-23.3%
609,675
+3.7%
0.00%0.0%
Q1 2016$4,363,000
-11.7%
587,975
-1.1%
0.00%0.0%
Q4 2015$4,941,000
-10.5%
594,611
-3.0%
0.00%
-50.0%
Q3 2015$5,523,000
-38.9%
612,984
-18.6%
0.00%0.0%
Q2 2015$9,032,000
+48.4%
752,745
+33.2%
0.00%0.0%
Q1 2015$6,088,000
+127.2%
565,217
+7.0%
0.00%
+100.0%
Q4 2014$2,679,000
+88.0%
528,349
-2.1%
0.00%
Q3 2014$1,425,000
-61.8%
539,805
-41.7%
0.00%
-100.0%
Q2 2014$3,730,000
+76.5%
925,562
+100.6%
0.00%0.0%
Q1 2014$2,113,000
+21.1%
461,314
+14.7%
0.00%
Q4 2013$1,745,000
-41.3%
402,239
-46.7%
0.00%
Q3 2013$2,974,000
+277.9%
754,434
+102.5%
0.00%
Q2 2013$787,000372,6290.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2013
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders